Skip to main content
Dialogue Health Technologies Inc.
  • Overview
    • Why Invest
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEDAR Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Site Search
Français
  • Overview
    • Why Invest
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEDAR Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Board of Directors

  • Overview
    • Why Invest
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEDAR Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Board of Directors Carousel

Paul Desmarais III

Mr. Desmarais is the Chairman and CEO of Sagard Holdings Inc. since 2016, the Executive Chairman and Co-Founder of Portag3 Ventures and the Chairman and co-founder of Diagram. Within the investment portfolios of Portag3 Ventures and Sagard Holdings, he is the Chairman of Wealthsimple and Dialogue, a director of KOHO Financial and Grayhawk, and a board observer of Nesto. Mr. Desmarais is also a Senior Vice-President of Power Corporation of Canada since 2014. As a part of his responsibilities at the holdings, he sits on the boards of Groupe Bruxelles Lambert and Imerys S.A. Prior to his current role, Mr. Desmarais worked at Goldman Sachs in the Investment Banking Division, Investment Strategy Group and Special Situations Group, Imerys S.A. from 2010 to 2012 in supply chain management and strategy and Great-West Lifeco Inc. in risk management from 2012 to 2014. Mr. Desmarais earned a B.A. in economics from Harvard College and holds an MBA from INSEAD.

Norma Beauchamp

Ms. Beauchamp is a former pharmaceutical executive with Bayer AG and has been an independent consultant since 2009. She serves as a member of the board of directors of Aurora Cannabis Inc. since 2018 and Extendicare Inc. since 2019. Ms. Beauchamp currently chairs the Nominating and Governance Committee and serves on the HR and Compensation Committee at Aurora Cannabis Inc. since 2018. Previously, Ms. Beauchamp was President and Chief Executive Officer at Cystic Fibrosis Canada from 2014 to 2017 and was a member of the board of directors of Acerus Pharmaceuticals Corporation from 2015 to 2020 where she chaired the Nominating and Governance committee and served on the audit committee between 2015 and 2020 and MedReleaf Corp from 2017 to 2018 where she Chaired the Governance and Compensation Committee from 2017 to 2018. Norma gives back to her community as a board of director on the Ontario Caregivers Organization and ALS Canada. In addition, she is a council member of the National Research Council of Canada and an active member/mentor with Women Get on Board. Ms. Beauchamp earned a Bachelor of Business Administration from Bishop’s University and has completed the Director’s Education Program at the Rotman School of Management at the University of Toronto.

Cherif Habib

Mr. Habib has been CEO at Dialogue since 2016. Before co-founding Dialogue, Mr. Habib was CEO at EMcision, a medical device company, until it was acquired by Boston Scientific. Previously, he spent 3 years as a senior management consultant at McKinsey & Co and led early-stage technology companies. Mr. Habib earned a Bachelor of Computer Science from Concordia University and an MBA from the Wharton School of Business at the University of Pennsylvania. He is a member of the board of directors of the Chamber of Commerce of Metropolitan Montréal.

Tim Hodgson

Tim is a corporate director and currently serves as Chair of Hydro One. Tim also Chairs the board of Sagicor Financial Corporation Limited, a financial and life insurance company and sits on the board of the Public Sector Pension Investment Board (PSP Investments). Mr. Hodgson was Special Advisor to Mr. Mark Carney, Governor of the Bank of Canada from 2010 to 2012. From 1990 to 2010, Tim held various positions in New York, London, Silicon Valley and Toronto with Goldman Sachs and served as Chief Executive Officer of Goldman Sachs Canada from 2005 to 2010, with overall responsibilities for the firm’s operations, client relationships and regulatory matters.

His prior directorships include MEG Energy, Alignvest Acquisition Corporation, Alignvest Acquisition II Corporation, The Global Risk Institute, KGS-Alpha Capital Markets, Next Canada, the Ivey School of Business and Bridgepoint Health.

Tim holds a Masters of Business Administration from The Ivey School of Business at Western University and a Bachelor of Commerce from the University of Manitoba. He is a Fellow of the Institute of Chartered Professional Accountants (FCPA) and holds his ICD.D.

Melissa Kennedy

Ms. Kennedy is Executive Vice-President, Chief Legal Officer & Public Affairs at Sun Life. She is responsible for the company’s worldwide legal, compliance, corporate secretarial and public affairs functions and is the executive sponsor of sustainability at Sun Life.
Prior to joining Sun Life, Ms. Kennedy was Senior Vice-President, General Counsel and Corporate Affairs for the Ontario Teachers’ Pension Plan, one of Canada’s largest pension funds. She started her career in private practice, followed by roles as head of the prosecution team at the Ontario Securities Commission and as Vice-President, Associate General Counsel at a major Canadian bank. Ms. Kennedy is a founding member of Legal Leaders for Diversity, a group of Canadian General Counsel who promote diversity and inclusiveness in the legal community.

Paul Lepage

Mr. Lepage is an advisor and board member in information technology focused companies. Previously, Mr. Lepage was Chief Executive Officer of Intelerad Medical Systems from 2018 to 2020. Mr Lepage worked for TELUS from 2009-2018 and was President of TELUS Health & Payment Solutions from 2012-2018 and Chairman of TELUS Ventures from 2016 to 2018. Mr. Lepage earned a Bachelor of Engineering from Ecole Polytechnique, an MBA from Concordia University and has completed his Institute of Corporate Directors, Director designation at the ICD-Rotman Directors Education Program.

*Mr. Lepage is expected to be appointed a director of the Company immediately prior to, or concurrent with, the consummation of the Offering.

Jean-François Marcoux

Mr. Marcoux has been Co-Founder and Managing Partner of White Star Capital since 2014 and is a board member of several technology companies. Previously, Mr. Marcoux was Co-Founder, Executive Vice-President and Chief Financial Officer of Ludia Inc. from 2007 to 2013, Senior Director, Mergers and Acquisitions at TC Transcontinental from 2003 to 2007 and worked at Scotia Capital in the Investment Banking Division from 2000 to 2003. Mr. Marcoux earned a Bachelor of Business Administration from the HEC at the University of Montréal and a Master of Finance from the University of Sherbrooke and is a Chartered Financial Analyst.

Mathieu Provost

Mr. Provost is Managing Director, Investments at the Caisse de dépot et placement du Québec since 2016. Previously, Mr. Provost was Investment Director at Anges Québec Capital, S.E.C. from 2015 to 2016, Director of Major Accounts at Investissement Québec from 2012 to 2015 and Manager, Investments at Telesystem LTD. and related entities from 2006 to 2012. Between 2010 and 2012, Mr. Provost was a member of the board of X20 Media where he served on the audit and compensation committee. Mr. Provost currently serves on several boards and, since 2017, Mr. Provost is also a member of the board of Glutenberg Craft Brewery where he serves on the finance and human resource committee since 2019. Mr. Provost earned a Bachelor of Business Administration in Finance from the HEC at the University of Montréal and is a Chartered Financial Analyst.

Dialogue Health Technologies Inc.

Follow us

  • follow us on facebook
  • follow us on twitter
  • follow us on linkedin

IR Contact

investors@dialogue.co

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Dialogue Health Technologies Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ?unsubscribe? section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Dialogue Health Technologies Inc. to send you the requested Investor Email Alert updates.

* Required

Pour vous abonner aux alertes par courriel destinées aux investisseurs, veuillez indiquer votre adresse courriel dans le champ ci-dessous et sélectionner au moins une option d'alerte. Une fois que vous aurez soumis votre demande, vous recevrez un courriel d'activation à l'adresse courriel indiquée. Vous devez cliquer sur le lien d'activation pour terminer votre abonnement. Vous pouvez vous abonner à d'autres options d'alertes en tout temps.

Chez Dialogue Technologies de la santé inc., nous promettons de traiter vos données avec respect et de ne pas divulguer vos renseignements à des tiers. Vous pouvez vous désabonner des alertes destinées aux investisseurs auxquelles vous êtes abonné(e) en vous rendant à la section < se désabonner > ci-dessous. Si vous éprouvez des difficultés, n'hésitez pas à communiquer avec vous pour obtenir de l'aide.

En indiquant votre adresse courriel ci-dessous, vous consentez à ce que Dialogue Technologies de la santé inc. vous envoie les alertes par courriel destinées aux investisseurs que vous avez demandées.

* Obligatoire

*
*




Unsubscribe

Email Alert Sign Up Confirmation

  • Privacy Policy
  • Terms of Use
Dialogue ©
Powered By Q4 Inc. 5.91.0.8 (opens in new window)